insights_auto
Why is ALCLS down 2.30%?
Dive Deeperchevron_right
ALCLS:EPA
Cellectis SA
€1.10
arrow_downward
-2.30%(-0.026) 1D
Oct 29, 5:35:22 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCLS...
Open
€1.14
High
€1.17
Low
€1.09
Mkt. cap
79.09M
Avg. vol.
439.01K
Volume
501.28K
52-wk high
€4.75
52-wk low
€0.90
EPS
-€0.58
Shares outstanding
72.09M
No. of employees
227
Open
€1.14
High
€1.17
Low
€1.09
Mkt. cap
79.09M
Avg. vol.
439.01K
Volume
501.28K
52-wk high
€4.75
52-wk low
€0.90
EPS
-€0.58
Shares outstanding
72.09M
No. of employees
227
News stories
From web sources and news partners
Idéal Investisseur
·
1 day ago
Cellectis share price rises above €0.94 and rebounds by nearly 16%
Profile
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina. Wikipedia
About Cellectis SA